Results 281 to 290 of about 1,647,697 (336)
Arthritis Care &Research, Accepted Article.Objective Recent inflammatory bowel disease (IBD) treatment guidelines have recommended against NSAID use despite prevalent musculoskeletal symptoms and opioid overuse in this population. Given the discordance between changing national guidelines and potential clinical utility, we sought to assess national temporal trends in prescription NSAID and ...
Adam S. Mayer +5 more
wiley +1 more source
Assessment of Pain Types in Recently Diagnosed Patients With Inflammatory Arthritis
Arthritis Care &Research, EarlyView.Objective Up to 40% of patients with inflammatory arthritis (IA) experience persistent pain, traditionally thought to be associated with a shift from peripherally to centrally mediated pain during the disease course in some patients. We assessed sensory profiles of recently diagnosed individuals with IA, hypothesizing that pain reported at this early ...
Zoe Rutter‐Locher +8 more
wiley +1 more source
The impact of positive lifestyle behaviors on direct healthcare cost savings for low back pain
Arthritis Care &Research, Accepted Article.Objective This study aimed to investigate the relationship between a previously purpose‐developed lifestyle behavior scale and healthcare cost savings related to low back pain (LBP). Methods This longitudinal study utilised data from the AUstralian Twin BACK (AUTBACK) study. LBP and lifestyle behavior measures were collected at baseline.
Ye Tian +8 more
wiley +1 more source
Health Utility In Chronic Migraine Sufferers: Assessing Quality Adjusted Life-Years
Adlai Pappy
openalex +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Practical Neurology, 2008
Many health systems now use cost-effectiveness analysis to decide which interventions and programmes to fund. A key issue for such decision making is how to measure health outcomes from interventions to reflect changes in both health-related quality of life and life expectancy.
Yolanda Bravo Vergel, Mark Sculpher
openaire +4 more sources
Many health systems now use cost-effectiveness analysis to decide which interventions and programmes to fund. A key issue for such decision making is how to measure health outcomes from interventions to reflect changes in both health-related quality of life and life expectancy.
Yolanda Bravo Vergel, Mark Sculpher
openaire +4 more sources
Utilities and Quality-Adjusted Life Years
International Journal of Technology Assessment in Health Care, 1989Utilities and quality-adjusted life years (QALYs) are reviewed, with particular focus on their use in technology assessment. This article provides a broad overview and perspective on these two techniques and their interrelationship, with reference to other sources for details of implementation.
David Feeny, George W. Torrance
openaire +3 more sources
Quality adjusted life years as expected utilities [PDF]
Spanish Economic Review, 2000 Abstract. This article is intended to systematicaly show all the conditions that the Quality Adjusted Life Year (QALY) must satisfy so that it can be interpreted as a von Newman-Morgenstern utility. Such conditions cover two cases. When health states are chronic, we shall be referring to the conditions inferred by Pliskin, Shepard and Weinstein (1980).
José Ma. Abellán Perpiñán +1 more
openaire +2 more sources
Not all “quality-adjusted life years” are equal
Journal of Clinical Epidemiology, 2007There is evidence that utility elicitation methods used in the calculation of quality-adjusted life years (QALYs) yield different results. It is not clear how these differences impact economic evaluations.Using a mathematical model incorporating data on efficacy, costs, and utility values, we simulated the experiences of 100,000 hypothetical rheumatoid
John M. Esdaile +10 more
openaire +3 more sources